OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A comprehensive study of SARS-CoV-2 main protease (Mpro) inhibitor-resistant mutants selected in a VSV-based system
Francesco Costacurta, Andrea Dodaro, David Bante, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Francesco Costacurta, Andrea Dodaro, David Bante, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Showing 8 citing articles:
An orally bioavailable SARS-CoV-2 main protease inhibitor exhibits improved affinity and reduced sensitivity to mutations
Michael Westberg, Yichi Su, Xinzhi Zou, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 738
Open Access | Times Cited: 12
Michael Westberg, Yichi Su, Xinzhi Zou, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 738
Open Access | Times Cited: 12
Emerging SARS-CoV-2 Resistance After Antiviral Treatment
Trevor J M Tamura, Manish C. Choudhary, Rinki Deo, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2435431-e2435431
Open Access | Times Cited: 7
Trevor J M Tamura, Manish C. Choudhary, Rinki Deo, et al.
JAMA Network Open (2024) Vol. 7, Iss. 9, pp. e2435431-e2435431
Open Access | Times Cited: 7
Study of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir
Laura Krismer, Helge Schöppe, Stefanie Rauch, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Laura Krismer, Helge Schöppe, Stefanie Rauch, et al.
npj Viruses (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Thermal Titration Molecular Dynamics: The Revenge of the Fragments
Matteo Pavan, Silvia Menin, Andrea Dodaro, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
Matteo Pavan, Silvia Menin, Andrea Dodaro, et al.
Journal of Chemical Information and Modeling (2025)
Open Access
Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system
Stefanie Rauch, Francesco Costacurta, Helge Schöppe, et al.
Antiviral Research (2024) Vol. 231, pp. 105969-105969
Open Access | Times Cited: 3
Stefanie Rauch, Francesco Costacurta, Helge Schöppe, et al.
Antiviral Research (2024) Vol. 231, pp. 105969-105969
Open Access | Times Cited: 3
Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections
Selwyn J. Hurwitz, Ramyani De, Julia C. LeCher, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 651-651
Open Access | Times Cited: 2
Selwyn J. Hurwitz, Ramyani De, Julia C. LeCher, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 651-651
Open Access | Times Cited: 2
Phytoconstituents of Citrus limon (Lemon) as Potential Inhibitors Against Multi Targets of SARS‐CoV‐2 by Use of Molecular Modelling and In Vitro Determination Approaches
Kannan Raman, Kalirajan Rajagopal, Fahadul Islam, et al.
ChemistryOpen (2024)
Open Access | Times Cited: 1
Kannan Raman, Kalirajan Rajagopal, Fahadul Islam, et al.
ChemistryOpen (2024)
Open Access | Times Cited: 1
Identification of key residues in MERS-CoV and SARS-CoV-2 main proteases for resistance against clinically applied inhibitors nirmatrelvir and ensitrelvir
Laura Krismer, Helge Schöppe, Stefanie Rauch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Laura Krismer, Helge Schöppe, Stefanie Rauch, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
